| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/13/2010 | US7695729 Nonoral preparation having three-layer structure |
| 04/13/2010 | US7695725 also comprises nucleic acid molecule (modified by contact with a psoralen activated by ultraviolet radiation) encoding non-Listerial antigen; immunogens; antigen presenting cells |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2422377C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2418848C Cng2b: a novel human cyclic nucleotide-gated ion channel |
| 04/13/2010 | CA2408707C Compositions and methods for the treatment of cancer |
| 04/13/2010 | CA2407683C Topical anesthetic/opioid formulations and uses thereof |
| 04/13/2010 | CA2394229C Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
| 04/13/2010 | CA2383372C Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 04/13/2010 | CA2379626C Antibacterial composition |
| 04/13/2010 | CA2345809C 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors |
| 04/13/2010 | CA2263675C Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders |
| 04/08/2010 | WO2010039248A1 Methods for the treatment of cancer |
| 04/08/2010 | WO2010039054A1 Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis |
| 04/08/2010 | WO2010038610A1 Novel cartilage cell proliferation and differentiation inducer |
| 04/08/2010 | WO2010038428A1 Alternative agent to taxane anti-cancer agent |
| 04/08/2010 | WO2010037715A1 Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| 04/08/2010 | WO2010037284A1 Polypeptides for treating or preventing cancers, the derivative products and uses thereof |
| 04/08/2010 | WO2010001096A3 Treatment |
| 04/08/2010 | WO2009117482A8 Mtor inhibitor salt forms |
| 04/08/2010 | WO2009013480A8 Antibacterial combination therapy |
| 04/08/2010 | US20100087547 Use of a Blood-Flow Decrease Preventing Agent in Conjunction With Insufflating Gas |
| 04/08/2010 | US20100087531 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 04/08/2010 | US20100087467 Compositions Useful As Inhibitors of Protein Kinases |
| 04/08/2010 | US20100087413 Prevention and treatment of inflammation-induced and/or immune-mediated bone loss |
| 04/08/2010 | US20100087404 Method of treating and preventing hyperparathyroidism with active vitamin d analogs |
| 04/08/2010 | US20100087391 Treatment of inflammatory bowel disease |
| 04/08/2010 | US20100086593 Dosage forms of bisphosphonates |
| 04/08/2010 | US20100086560 Chemokines as adjuvants of immune response |
| 04/08/2010 | US20100086557 Pharmaceutical composition for tumor treatment |
| 04/08/2010 | US20100086526 Nucleic acid constructs and methods for specific silencing of h19 |
| 04/08/2010 | US20100086523 Method for generating pluripotent stem cells |
| 04/08/2010 | US20100086521 Means For Regulating The Cosmetic Appearance And/Or Health Of Human Keratinous Tissue |
| 04/08/2010 | US20100086520 Compositions, Kits and Uses For Protecting The Skin Against Pathogenic Microorganisms |
| 04/08/2010 | DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors |
| 04/08/2010 | DE102008037682A1 Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen Use of equipotent doses of local anesthetics or derivatives thereof for the treatment of chronic pain |
| 04/08/2010 | CA2738868A1 Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| 04/08/2010 | CA2738583A1 Methods for the treatment of cancer |
| 04/07/2010 | EP2172560A2 stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 04/07/2010 | EP2172559A1 Screening method |
| 04/07/2010 | EP2172457A2 Fredericamycin derivatives |
| 04/07/2010 | EP2172246A2 Methods for Alzheimer's disease treatment and cognitive enhancement |
| 04/07/2010 | EP2172226A1 Method of fixing and expressing physiologically active substance |
| 04/07/2010 | EP2172224A1 Aqueous composition |
| 04/07/2010 | EP2172222A2 Novel BLT2-mediated disease, BLT2-binding agent and compound |
| 04/07/2010 | EP2172221A1 Composition for ophthalmic disease associated with hypoxia or ischemia |
| 04/07/2010 | EP2172217A1 Fibrosis inhibitor |
| 04/07/2010 | EP2172204A1 Methods of treating syndrome X with apliphatic polyamines |
| 04/07/2010 | EP2172197A1 Octanoic acid derivative to treat fibromyalgia and other pains |
| 04/07/2010 | EP2172192A1 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder of granular material, and process and tooling for producing it |
| 04/07/2010 | EP2172101A1 Normal-pressure glaucoma model and method of evaluating test substance by using the same |
| 04/07/2010 | EP2170398A1 Use of a synergistic composition as a therapeutic agent or disinfectant |
| 04/07/2010 | EP2170397A1 Methods and compositions for treating pulmonary hypertension and related diseases and disorders |
| 04/07/2010 | EP2170396A1 Drug combinations for the treatment of duchenne muscular dystrophy |
| 04/07/2010 | EP2170393A2 Antithrombotic agents and methods of use thereof |
| 04/07/2010 | EP2170335A1 Compositions comprising tryptophan hydroxylase inhibitors |
| 04/07/2010 | EP2170292A2 Tableted compositions containing atazanavir |
| 04/07/2010 | EP2170062A1 Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders |
| 04/07/2010 | EP1583559B1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers |
| 04/07/2010 | CN1578647B Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 04/07/2010 | CN1545551B Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 04/07/2010 | CN101691370A Triazolo[4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists |
| 04/07/2010 | CN101690822A Medicament carrier for targeted medicament delivery on diseases related to macrophage and preparation method thereof |
| 04/07/2010 | CN101690816A Medicinal composition of calcium-containing antagonist, A II receptor antagonist and statins |
| 04/07/2010 | CN101690815A Novel use of dipeptidyl peptidase-iv inhibitor |
| 04/07/2010 | CN101690814A Traditional Chinese medicine monomer having function of promoting growth of motoneuron |
| 04/07/2010 | CN101690744A synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| 04/07/2010 | CN101690713A Preparation method for carbostyril injection |
| 04/06/2010 | US7691973 GFRα3 polypeptides |
| 04/06/2010 | US7691907 Methods and composition based on discovery of metabolism of nitroglycerin |
| 04/06/2010 | US7691903 Oxidation-sensitive hydrophilic active principle containing composition and use thereof |
| 04/06/2010 | US7691890 Therapeutic treatment of virus infections; cell antigrowth agents; treating human herpes viruses |
| 04/06/2010 | US7691872 Administering compound that binds human serum albumin (HSA) to increase free drug levels of the camptothecin compound during anti-topoisomerase I-based therapy in human |
| 04/06/2010 | US7691871 Multivitamin syrup for children or young adults |
| 04/06/2010 | US7691862 Administering misoprostl and ciprofloxacin exceptional results in obtaining very significant regeneration of bone and cementum in periodontal pockets as determined by the very significant reduction in the depth of the periodontal pockets with or without surgical intervention |
| 04/06/2010 | US7691838 Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics |
| 04/06/2010 | US7691835 Therapy for prostate cancer; administering androgen receptor |
| 04/06/2010 | US7691832 Ulcerative colitis and Crohn's disease; 5-aminosalicylic acid or 4-aminosalicylic acid and one or more antioxidants (e.g., N-acetylcysteine) |
| 04/06/2010 | US7691828 Compositions for ameliorating fecal properties |
| 04/06/2010 | US7691819 Buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy, multiple chemical sensitivity syndrome, Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Roussy-Levy syndrome, Rosenberg Chutorian syndrome, Korsakoff syndrome |
| 04/06/2010 | US7691593 Regulation of lung tissue by patched therapeutics and formulations and uses related thereto |
| 04/06/2010 | US7691566 Compositions and methods for treatment of cancer |
| 04/06/2010 | US7691420 comprising a catechin as found in green tea, e.g., epigallocatechin gallate, and ligand which activates the peroxisome proliferatoractivated receptor gamma |
| 04/06/2010 | US7691412 dissolving active principle in water; emulsifying resulting solution of active principle with d,l-lactide-co-glycolide matrix copolymer, emulsifying first emulsion in external aqueous phase containing surfactant, viscosity-enhancing agent, osmotic agent, extraction-evaporation to form microspheres |
| 04/06/2010 | US7691404 Acrylate adhesive, a polyvinylpyrrolidone having a molecular weight of 1,000,000-5,000,000; a polyvinylpyrrolidone having a molecular weight of 2,000-50,000; a non-ionic surfactant; a terpene; and a dissolution assistant. |
| 04/06/2010 | US7691378 Treating carcinomas or adenocarcinomas using at least one anti-TNF (tumor necrosis factor) antibody |
| 04/06/2010 | US7691376 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes |
| 04/06/2010 | CA2358505C Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 04/06/2010 | CA2309195C Stable ascorbic acid preparation for topical use |
| 04/06/2010 | CA2280930C Protein markers for lung cancer and use thereof |
| 04/01/2010 | WO2010036975A2 Dipyridamole and acetylsalicylic acid formulations and process for preparing same |
| 04/01/2010 | WO2010035575A1 Melanin production inhibitor and skin-whitening cosmetic |
| 04/01/2010 | WO2010035074A1 Use of nitrous oxide, argon, xenon, helium, or neon, for the manufacture of a pharmaceutical composition for treating ischemic insults in patients who cannot be treated with thrombolytic agents |
| 04/01/2010 | WO2010034615A1 Immunostimulant compositions comprising a nucleobase and a polysaccharide obtainable from fungi, yeast or bacteria |
| 04/01/2010 | WO2010034128A1 Spy1a as a diagnostic and prognostic marker of cancer |
| 04/01/2010 | WO2010015827A3 Phosphate binding materials and their uses |
| 04/01/2010 | WO2010003057A3 Treating cancer |
| 04/01/2010 | WO2009154944A3 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds |
| 04/01/2010 | WO2009152374A3 Method for treating chronic wounds with an extracellular polymeric substance solvating system |
| 04/01/2010 | WO2009086952A3 Compositions for the treatment of degenerative articular diseases |